{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA021992"
        ],
        "brand_name": [
          "PRISTIQ"
        ],
        "generic_name": [
          "DESVENLAFAXINE SUCCINATE"
        ],
        "manufacturer_name": [
          "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
        ],
        "product_ndc": [
          "0008-1210",
          "0008-1211",
          "0008-1222"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DESVENLAFAXINE SUCCINATE"
        ],
        "rxcui": [
          "790267",
          "790290",
          "1607617",
          "1607619",
          "1874553",
          "1874559"
        ],
        "spl_id": [
          "f92cf4c4-e87c-48f1-bcd6-ed79d5534d01"
        ],
        "spl_set_id": [
          "0f43610c-f290-46ea-d186-4f998ed99fce"
        ],
        "package_ndc": [
          "0008-1211-50",
          "0008-1211-01",
          "0008-1211-14",
          "0008-1211-30",
          "0008-1222-01",
          "0008-1222-14",
          "0008-1222-30",
          "0008-1222-50",
          "0008-1210-30"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300081210306",
          "0300081222309",
          "0300081211303"
        ],
        "unii": [
          "ZB22ENF0XR"
        ]
      },
      "product_type": "Drugs",
      "event_id": "68001",
      "recalling_firm": "Pfizer Us Pharmaceutical Group",
      "address_1": "235 E 42nd St",
      "address_2": "N/A",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1409-2014",
      "product_description": "Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc.,  NDC 0008-1211-30",
      "product_quantity": "220,761 bottles",
      "reason_for_recall": "Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.",
      "recall_initiation_date": "20140416",
      "center_classification_date": "20140624",
      "termination_date": "20160920",
      "report_date": "20140702",
      "code_info": "H74477, H74478, Exp. 03/16,  H74479, H79766 Exp. 05/16"
    }
  ]
}